We are live on ! Find out more
Calamos Advisors

Calamos Advisors Portfolio holdings

AUM $28.2B
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
+0.71%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$22.9B
AUM Growth
+$1.01B
Cap. Flow
-$5.41B
Cap. Flow %
-23.63%
Top 10 Hldgs %
20.65%
Holding
1,090
New
128
Increased
343
Reduced
93
Closed
104

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$41.8M
2
AAPL icon
Apple
AAPL
+$35.4M
3
AMZN icon
Amazon
AMZN
+$34.6M
4
AESC
The AES Corporation
AESC
+$30.3M
5
ADBE icon
Adobe
ADBE
+$25.6M

Sector Composition

Rank Sector Weight
1 Technology 15.1%
2 Financials 8.11%
3 Healthcare 7.32%
4 Consumer Discretionary 6.91%
5 Communication Services 6.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMCIU
401
DELISTED
AMCI Acquisition Corp II Units
AMCIU
$5.95M 0.03%
+600,000
New +$5.92M
CLBR.U
402
DELISTED
Colombier Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant
CLBR.U
$5.92M 0.03%
600,000
+100,000
+20% +$989K
PSX icon
403
Phillips 66
PSX
$83.6B
$5.9M 0.03%
84,213
+7,430
+10% +$538K
STAA icon
404
STAAR Surgical
STAA
$1.19B
$5.86M 0.03%
45,599
+26,367
+137% +$3.69M
ZIP icon
405
ZipRecruiter
ZIP
$346M
$5.83M 0.03%
211,417
+92,737
+78% +$2.4M
SWAV
406
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$5.78M 0.03%
28,067
+19,041
+211% +$3.74M
ASPN icon
407
Aspen Aerogels
ASPN
$341M
$5.72M 0.03%
+124,258
New +$4.93M
LEG icon
408
Leggett & Platt
LEG
$1.4B
$5.68M 0.02%
126,611
+11,172
+10% +$538K
TTD icon
409
Trade Desk
TTD
$9.04B
$5.67M 0.02%
80,700
OXY icon
410
Occidental Petroleum
OXY
$55.6B
$5.63M 0.02%
190,244
+16,392
+9% +$438K
KCGI.U
411
DELISTED
Kensington Capital Acquisition Corp. V Units, each consisting of one Class A ordinary share and three-fourths of one redeemable warrant
KCGI.U
$5.61M 0.02%
+550,000
New +$5.57M
EIX icon
412
Edison International
EIX
$30.5B
$5.58M 0.02%
100,520
+8,870
+10% +$509K
NKE icon
413
PUT
Nike
NKE
$63.4B
$5.52M 0.02%
+38,000
New +$6.2M
MELI icon
414
Mercado Libre
MELI
$94.4B
$5.46M 0.02%
3,249
+2,617
+414% +$4.53M
AGGRU
415
DELISTED
Agile Growth Corp Units
AGGRU
$5.45M 0.02%
550,000
AMG icon
416
Affiliated Managers Group
AMG
$9.63B
$5.35M 0.02%
35,430
TWLVU
417
DELISTED
Twelve Seas Investment Company II Unit
TWLVU
$5.32M 0.02%
537,329
GXIIU
418
DELISTED
GX Acquisition Corp. II Unit
GXIIU
$5.29M 0.02%
533,506
RBCP
419
DELISTED
RBC Bearings Incorporated 5.00% Series A Mandatory Convertible Preferred Stock
RBCP
$5.25M 0.02%
+47,143
New +$5.46M
PVH icon
420
PVH
PVH
$3.99B
$5.24M 0.02%
51,015
+4,502
+10% +$485K
SAIA icon
421
Saia
SAIA
$10.5B
$5.24M 0.02%
22,016
-2,268
-9% -$524K
ASAXU
422
DELISTED
Astrea Acquisition Corp. Unit
ASAXU
$5.23M 0.02%
511,397
FIGS icon
423
FIGS
FIGS
$1.78B
$5.06M 0.02%
+136,191
New +$5.49M
AGAC.U
424
DELISTED
African Gold Acquisition Corp Units
AGAC.U
$5.05M 0.02%
500,000
APACU
425
DELISTED
StoneBridge Acquisition Corporation Unit
APACU
$5.04M 0.02%
+500,000
New +$5M

Similar funds

Calamos Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Calamos Advisors held 1,090 positions worth $22.9B, up 4.6% from $21.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Calamos Advisors withdrew a net $5.41B in Q3 2021, closing 104 positions and reducing 93 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $31.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Calamos Advisors opened a new position in AstraZeneca worth $17.8M.

  • Calamos Advisors's largest Q3 2021 buy was AstraZeneca: 148,454 shares worth $17.8M.
  • Calamos Advisors added most to Microsoft in Q3 2021, an estimated $41.8M increase.
  • Calamos Advisors's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $236M.
  • Calamos Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $31.2M.
  • Calamos Advisors's ten largest holdings make up 21% of its $22.9B portfolio in Q3 2021.
  • Calamos Advisors opened 128 new positions and closed 104 in Q3 2021.
  • Calamos Advisors's portfolio value rose 4.6% quarter-over-quarter to $22.9B.

Based on Calamos Advisors's 13F filing for Q3 2021, filed 26 Oct 2021.